观点：他汀类药物为何几乎未能降低任何人的死亡率。 - Suppr | 超能文献

Point: why statins have failed to reduce mortality in just about anybody.

作者信息

Vos Eddie, Rose Colin P, Biron Pierre

出版信息

J Clin Lipidol. 2013 May-Jun;7(3):222-4. doi: 10.1016/j.jacl.2013.01.007. Epub 2013 Feb 8.

DOI:10.1016/j.jacl.2013.01.007

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Point: why statins have failed to reduce mortality in just about anybody.观点：他汀类药物为何几乎未能降低任何人的死亡率。

J Clin Lipidol. 2013 May-Jun;7(3):222-4. doi: 10.1016/j.jacl.2013.01.007. Epub 2013 Feb 8.

2

Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials.他汀类药物在预防系统性红斑狼疮患者动脉粥样硬化中的疗效与安全性——一项随机对照试验的荟萃分析

Int J Cardiol. 2013 Jul 15;167(1):301-3. doi: 10.1016/j.ijcard.2012.09.190. Epub 2012 Oct 16.

3

Statins, primary prevention, and overall mortality.他汀类药物、一级预防与全因死亡率。

Ann Intern Med. 2014 Jun 17;160(12):867-9. doi: 10.7326/M13-2974.

4

[Primary prevention trials performed with statins prior to the JUPITER trial].[在JUPITER试验之前使用他汀类药物进行的一级预防试验]

Turk Kardiyol Dern Ars. 2009 Apr;37 Suppl 4:14-7.

5

Statins reduce stroke risk by one-fifth.他汀类药物可将中风风险降低五分之一。

Cardiovasc J Afr. 2009 May-Jun;20(3):208-9.

6

[HMG-CoA reductase inhibitors: a brief review of their pharmacological properties and clinical efficacy in cardiovascular disease].[HMG-CoA还原酶抑制剂：其药理学特性及在心血管疾病中的临床疗效简述]

Rev Port Cardiol. 1999 Jan;18(1):65-76.

7

The grapefruit-drug interaction debate: role of statins.西柚与药物相互作用的争论：他汀类药物的作用

Am Fam Physician. 2007 Jul 15;76(2):190, 192; author reply 192.

8

The use of statins in pediatrics: knowledge base, limitations, and future directions.他汀类药物在儿科的应用：知识基础、局限性及未来方向。

Pediatrics. 2007 Feb;119(2):370-80. doi: 10.1542/peds.2006-0787.

9

Are statins effective in high-risk primary prevention?他汀类药物在高危一级预防中是否有效？

Arch Intern Med. 2010 Dec 13;170(22):2042-3; author reply 2043-4. doi: 10.1001/archinternmed.2010.458.

10

Potentials and pitfalls of meta-analysis on statins.

Am J Med. 2008 Jan;121(1):e3; author reply e5. doi: 10.1016/j.amjmed.2007.08.034.

引用本文的文献

1

Longitudinal lipid trends and adverse outcomes in patients with CKD: a 13-year observational cohort study.慢性肾脏病患者的纵向脂质趋势和不良结局：一项为期 13 年的观察性队列研究。

J Lipid Res. 2019 Mar;60(3):648-660. doi: 10.1194/jlr.P084590. Epub 2019 Jan 14.